Trial intelligence / Profile preview

Adherence Measurement in Stable Renal Transplant Patients Following Conversion from Prograf to Advagraf

2008-003231-20Phase 4Completed

Sponsor
KU Leuven
Start
Aug 2008
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of tacrolimus in kidney allograft rejection (2 arms), sponsored by KU Leuven. Primary endpoint: Post-baseline taking adherence comparison. Started Aug 2008; status: completed.

02

Drugs

tacrolimus
03

Conditions

kidney allograft rejection

Beyond the preview

Go deeper on 2008-003231-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-003231-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call